← Leaderboards
Benjamin Moon
Ut Southwestern Medical Center
$159,773
Attributed
$159,773
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2021–24$100K$75K$50K$25K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$159,773 · 1
By mechanism
F30$159,773 · 1
Top collaborators
No co-investigators on record.
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Philipp E Scherer$40,932,820
- Abhimanyu Garg$28,553,253
- Helen H. Hobbs$30,094,310
- Jay D Horton$17,439,528
- Margaret A. Phillips$30,430,817
Others in their field
Other Emerging Leaders on “Accounting”
- Martha Hering · Westat, Inc.$57,098,843
- John Hobbs · Suny At Stony Brook$41,239,084
- Christopher Bee · Suny At Stony Brook$41,239,084
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Pamela Winer Goldberg · Medical Device Innovation Consortium$28,780,000
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,689,457
Research focus
AccountingAdoptive TransferAcidityAffinityAntibodiesAntitumor EffectAntitumor ResponseAdverse EffectsBindingBiodistributionBiological MarkersBloodBody WeightBody Weight DecreasedBody Weights And MeasuresC57bl/6 MouseCancer ImmunotherapyCause Of DeathCd8b1 GeneCd8-Positive T-LymphocytesCell Differentiation ProcessCellsCell TypeCellular Immunity
Grant awards (4)
Development of a tumor-activated IL12 prodrug to treat solid tumors$24,724
F30 · FY2024 · CA · contact PI
Development of a tumor-activated IL12 prodrug to treat solid tumors$46,752
F30 · FY2023 · CA · contact PI
Development of a tumor-activated IL12 prodrug to treat solid tumors$51,752
F30 · FY2022 · CA · contact PI
Development of a tumor-activated IL12 prodrug to treat solid tumors$36,545
F30 · FY2021 · CA · contact PI